- Home
- >
- Mexico
- >
- Regulatory Affairs
Regulatory Affairs Consulting Services in Mexico
Get expert support for regulatory affairs in Mexico across the life sciences sector. We simplify compliance so you can focus on your product’s success.

Services We Offer
Enter the Mexican Market with Regulatory Compliance
Mexico is one of the largest healthcare markets in Latin America after Brazil, with growing demand for advanced therapies and pharmaceutical solutions. This presents a strong global opportunity for companies looking to enter the market. The product approval process in Mexico involves meeting defined regulatory standards before products can be introduced. Artixio offers regulatory affairs solutions in Mexico to support companies through local requirements and registration procedures.
COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), the Mexican regulatory affairs authority was established in 2001. It works under Mexico’s Ministry of Health and is responsible for the regulation of safety, efficacy and quality of health-related products in Mexico. It requires a strict multi-step process to launch any healthcare product in Mexico.
COFEPRIS is recognized by the Pan American Health Organization (PAHO) as a National Regulatory Authority (NRA) of regional reference. This helps other Latin American countries for regulatory approvals and decreases redundant reviews. It elevates COFEPRIS as a benchmark regulator in the region, making Mexico as a key entry point for pharmaceutical companies looking to enter Latin America.
Artixio, a trusted regulatory affairs company in Mexico, supports businesses in launching their products without hassles by providing strategic services for registration and approvals.
Regulatory Authorities in Mexico
The primary body for regulating pharmaceuticals, medical devices, and health-related products.
Responsible for agricultural products, food safety, and quality control.
Regulates packaging, labeling, and product import/export compliance.
Regulates health standards for health-related products.
Regulatory Affairs Lifecycle in Mexico

The first technical checkpoint is to analyse the correct classification and regulatory pathway for the product. COFEPRIS assesses the classification based on composition, primary mechanism of action, intended use, and route of administration.
- Medical devices are classified into four risk classes (Class I to IIIb).
- Pharmaceuticals are categorized as new molecules, generics, OTCs, or biocomparables.
- Nutritionals and cosmetics are further distinguished as either regulated or exempt products, based on ingredients and claims.

Compile a structured dossier with localized content which includes the following:
- Administrative forms
- Product composition and labeling
- Manufacturing process and site information
- Certificates of Free Sale (for imported goods)
- GMP certificates (from recognized NRAs or via direct COFEPRIS inspection)
- Quality testing reports
- Clinical evidence or performance studies (if applicable)
- Sample packaging or mock-ups
All documents must be submitted in Spanish, including translation of original SmPCs, labels, and technical data.
Note:
- For Medical Devices: the dossier must also include risk classification, QMS documentation, and a technical file equivalent to STED.
- For pharmaceuticals and Biologics: Clinical trial data is required, depending on the status of global approvals.
- For nutritionals, cosmetics, and veterinary products: COFEPRIS has different templates and forms for these. However, all submissions must include safety justification, labeling proposals, and a valid Certificate of Free Sale from the country of origin.

It is important for all foreign companies to appoint a Mexican Registration Holder (MRH). MRH is responsible for maintaining the regulatory license and is accountable for COFEPRIS regulatory compliance.

It is important for manufacturing sites to be GMP-compliant for imported products. Note that the site registration should be done before or concurrently with the product registration.

Submit the dossier to COFEPRIS which then goes through a completeness evaluation followed by a technical evaluation (if the application is complete). Additional information is requested by issuing a deficiency letter, in case of data incompleteness. Also, they may ask for clarifications, additional data, or corrected translations during review.

COFEPRIS grants a Sanitary Registration Certificate (Registro Sanitario) with a unique alphanumeric (Sanitary Registration Number) code after a successful review.
This number should reflect on the secondary packaging, Instructions For Use (IFU), and marketing materials. For medical devices, it should also be included in import documentation.

Post marketing compliance is mandatory for products after launching in the market. It is important to report Adverse events, Periodic Safety Update Reports (PSURs) submissions, notification to COFEPRIS if there is any modification in labeling, shelf life, etc. It is also necessary to renew the product license every five years and it should be filed at least 90 days before expiry.
Why Artixio for Regulatory Affairs in Mexico
- Local expertise in Mexico’s regulatory environment
- End-to-end support from product concept to market entry
- Strong relationships with Mexican regulatory authorities
- In-house team with 30+ years of experience
- Integrated GMP, QMS, and PV support
- Focused on compliance, speed, and successful approvals
Partner with Artixio today to register your product with precision. Our team of experts supports and manages your regulatory filings in Mexico with compliance. Contact our Regulatory Affairs consultant in Mexico today to register your product without delays.
FAQs
What are the two possible routes for GMP compliance?
There are two possible routes including:
- Recognition-based pathway: COFEPRIS accepts the registration under mutual recognition if the facility has GMP certification from the FDA, EMA, Health Canada, or other recognized agencies.
- Direct inspection pathway: COFEPRIS conducts its own inspection of the facility, particularly for high-risk pharmaceuticals or biologics.
Can we use a third-party for our MRH?
Yes, you can appoint a local entity such as Artixio as your MRH or work with a partner designated through a formal agreement.
Are there any specific labeling requirements in Mexico?
What types of products require COFEPRIS approval?
Do all sites need COFEPRIS inspection?
If your facility is GMP-certified by a recognized agency (such as FDA, EMA), it may not be required.
Can I market my product in Mexico if it is approved in another country?
How can I maintain regulatory compliance in Mexico once my product is approved?
Still Have Questions ?
Industries We Serve in the Mexico
Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy

Medical & Technical Writing

Publishing & Submission






Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea
Insights from Artixio - Tips & Articles

In Vitro Diagnostics: Meaning,
The term “in vitro” is a Latin word that means “in glass”. Thus, from...

IVD Medical Devices Registration
The in vitro diagnostic in India is regulated by the Central Drugs Standard Control...

Pharma Manufacturing Booms in
Once overlooked pharma hub in Mexico's Hidalgo region has gained importance with global market...